The cancer tissue page shows antibody staining in 20 different cancers. The overall cancer tissue staining statistics shows the fraction of patient samples with strong, moderate, weak or no staining (as described by the color-coding scale in the box to the right), using all the available antibodies to the protein targets encoded by this gene. The assay and annotation is described here.
The cancers can be ordered histologically or alphabetically.
For each cancer, the staining for each available antibody is reported as the fraction of samples with strong, moderate, weak or no staining (as described by the color-coding scale in the box to the right). The lenght of the bar represents the number of patient samples analysed (max=12 patients). By clicking on a cancer tissue, the detailed staining data for that cancer is available, including annotated images.
At the bottom of this page, a summary for the cancer staining for each antibody is given, together with the immunohistochemistry validation score for that antibody.
Most malignancies showed weak cytoplasmic or nuclear positivity or were negative.
Most malignancies showed weak cytoplasmic positivity or were negative.
A majority of malignant carcinoids and several colorectal, ovarian, cervical, lung, pancreatic and liver cancers showed moderate cytoplasmic staining. Most of the remaining malignancies were weakly stained or negative.
A single case of malignant carcinoid showed strong cytoplasmic staining. Subsets of cells in a few cases of colo-rectal, ovarian, endometrial, testicular and liver cancers revealed weak to moderate cytoplasmic and/or nuclear immunoreactivity. Other malignant tissues were negative.
Validation
Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
